CD4 and neoplasm: The outcomes observed with combined PD-1 and CTLA-4 blockade were found to correlate with an increase in CD4+ effector T cell (CD4+ Teff) to Treg cell ratio and CD8+ T cell to Treg cell ratio in tumor tissue.